Modification of pharmacological activity of nebivolol due to Maillard reaction

Author： Patil Dipak D. Patil Chandragouda R.

ISSN： 1083-7450

Source： Pharmaceutical Development and Technology, Vol.18, Iss.4, 2013-08, pp. : 844-851

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carvedilol superior to nebivolol for HF due to cardiomyopathy

Inpharma, Vol. 1, Iss. 1519, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Lack of inverse agonistic activity of nebivolol, its d- and l-enantiomers and of in vivo metabolized nebivolol in human myocardium

By Bundkirchen A. Nguyen Q. Brixius K. Bolck B. Mehlhorn U. Schwinger R.H.G.

European Journal of Pharmacology, Vol. 476, Iss. 1, 2003-08 ,pp. : 97-105

Elsevier

Access to resources Recommend Favorite

Concerning the wound-healing properties of Sphagnum holocellulose: the Maillard reaction in pharmacology

By Painter T.J.

Journal of Ethnopharmacology, Vol. 88, Iss. 2, 2003-10 ,pp. : 145-148

Elsevier

Access to resources Recommend Favorite

Can Dietary Polyphenols Prevent the Formation of Toxic Compounds from Maillard Reaction?

Current Drug Metabolism, Vol. 17, Iss. 6, 2016-05 ,pp. : 598-607

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of Biomarkers for Pharmacological Activity

By Alonso Ariel

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 2, 2009-03 ,pp. : 256-272

Taylor & Francis Ltd

Access to resources Recommend Favorite